Literature DB >> 19819896

Implementing a standardized community-based cardiovascular risk assessment program in 20 Ontario communities.

Megan Carter1, Tina Karwalajtys, Larry Chambers, Janusz Kaczorowski, Lisa Dolovich, Tracy Gierman, Dana Cross, Stephanie Laryea.   

Abstract

The aim of the study is to describe the implementation of the Cardiovascular Health Awareness Program (CHAP) in 20 mid-sized communities across Ontario, Canada, and identify key factors in the successful multi-site delivery of a collaborative cardiovascular risk assessment and management program. Lead organizations were identified and contracted following a request for proposals. An Implementation Guide detailed steps in community mobilization and delivery of volunteer-led pharmacy-based cardiovascular risk assessment sessions. Process data were collected through final reports; a debriefing meeting; and interviews with program staff. All 20 communities successfully implemented CHAP. Overall, 99% (338/341) of family physicians agreed to receive assessment results and 89% (129/145) of pharmacies held sessions. Five hundred and seventy-seven volunteers conducted 27,358 risk assessments for 15,889 unique participants. Essential program components were consistently included, however, variations in materials, processes and support occurred. Factors in program success included: local expertise, centralized support, identification and engagement of local physician and pharmacist opinion leaders and a balance of standardization and flexibility. Monitoring delivery of a multi-community cardiovascular risk assessment program yielded key factors in program success to inform development of a sustainable and transferable model.

Entities:  

Mesh:

Year:  2009        PMID: 19819896     DOI: 10.1093/heapro/dap030

Source DB:  PubMed          Journal:  Health Promot Int        ISSN: 0957-4824            Impact factor:   2.483


  13 in total

Review 1.  Risk scoring for the primary prevention of cardiovascular disease.

Authors:  Kunal N Karmali; Stephen D Persell; Pablo Perel; Donald M Lloyd-Jones; Mark A Berendsen; Mark D Huffman
Journal:  Cochrane Database Syst Rev       Date:  2017-03-14

2.  Barriers and facilitators to recruitment of physicians and practices for primary care health services research at one centre.

Authors:  Sharon Johnston; Clare Liddy; William Hogg; Melissa Donskov; Grant Russell; Elizabeth Gyorfi-Dyke
Journal:  BMC Med Res Methodol       Date:  2010-12-13       Impact factor: 4.615

3.  Attendance, activation and health profiles of participants, a prospective study on a regional cardiometabolic disease self-management program in Laval, Canada.

Authors:  Magali Girard; Janusz Kaczorowski; Marie-Thérèse Lussier; Vivianne Martin
Journal:  BMC Public Health       Date:  2021-03-12       Impact factor: 3.295

4.  Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP).

Authors:  Janusz Kaczorowski; Larry W Chambers; Lisa Dolovich; J Michael Paterson; Tina Karwalajtys; Tracy Gierman; Barbara Farrell; Beatrice McDonough; Lehana Thabane; Karen Tu; Brandon Zagorski; Ron Goeree; Cheryl A Levitt; William Hogg; Stephanie Laryea; Megan Ann Carter; Dana Cross; Rolf J Sabaldt
Journal:  BMJ       Date:  2011-02-07

5.  A community pharmacy-based cardiovascular risk screening service implemented in Iran.

Authors:  Zahra Jahangard-Rafsanjani; Negar Hakimzadeh; Amir Sarayani; Sheyda Najafi; Kazem Heidari; Mohammad R Javadi; Molouk Hadjibabaie; Kheirollah Gholami
Journal:  Pharm Pract (Granada)       Date:  2017-06-30

6.  Criteria for evaluating transferability of health interventions: a systematic review and thematic synthesis.

Authors:  Tamara Schloemer; Peter Schröder-Bäck
Journal:  Implement Sci       Date:  2018-06-26       Impact factor: 7.327

7.  Design and rationale for a pragmatic cluster randomized trial of the Cardiovascular Health Awareness Program (CHAP) for social housing residents in Ontario and Quebec, Canada.

Authors:  Gina Agarwal; Magali Girard; Ricardo Angeles; Melissa Pirrie; Marie-Thérèse Lussier; Francine Marzanek; Lisa Dolovich; J Michael Paterson; Lehana Thabane; Janusz Kaczorowski
Journal:  Trials       Date:  2019-12-23       Impact factor: 2.279

8.  Feasibility of cardiovascular risk screening in Portuguese community pharmacies.

Authors:  Anabela A Fonseca; Tácio M Lima; Margarida Castel-Branco; Isabel V Figueiredo
Journal:  Pharm Pract (Granada)       Date:  2021-05-25

9.  Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey.

Authors:  Robert J Petrella; Guy Tremblay; Guy De Backer; Dawn P Gill
Journal:  Vasc Health Risk Manag       Date:  2014-01-29

10.  Long term outcomes of cluster randomized trial to improve cardiovascular health at population level: The Cardiovascular Health Awareness Program (CHAP).

Authors:  Simone Dahrouge; Janusz Kaczorowski; Lisa Dolovich; Michael Paterson; Lehana Thabane; Karen Tu; Jaime Younger; Larry Chambers
Journal:  PLoS One       Date:  2018-09-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.